What is a Bubble Contrast Study?
A bubble contrast study is an echocardiographic technique where agitated saline containing microbubbles is injected intravenously during ultrasound imaging to detect intracardiac shunts (like patent foramen ovale) and intrapulmonary shunts (like pulmonary arteriovenous malformations). 1
Core Principle and Mechanism
The technique exploits the fact that microbubbles created from agitated saline are approximately the size of red blood cells (<7 µm diameter) and act as highly echogenic ultrasound contrast agents. 2, 3 These bubbles cannot normally cross the pulmonary capillary bed—they are filtered out by the lungs. 1 Therefore, if bubbles appear in the left heart chambers, this indicates an abnormal right-to-left shunt either through the heart itself or through the pulmonary vasculature. 1, 4
How the Test Distinguishes Between Shunt Types
The timing of bubble appearance in the left atrium is the critical diagnostic feature:
Intracardiac shunt (Patent Foramen Ovale): Bubbles appear in the left atrium within 3-4 cardiac cycles after appearing in the right atrium, because they pass directly from right to left heart without traversing the lungs. 1, 4
Intrapulmonary shunt (Pulmonary Arteriovenous Malformation): Bubbles appear after 3-8 cardiac cycles, because they must pass through abnormal pulmonary vascular connections before reaching the left heart. 1, 4
Clinical Applications
Detection of Patent Foramen Ovale
The American Heart Association recommends bubble studies to identify patients who might benefit from PFO closure to prevent recurrent stroke, particularly in cryptogenic stroke patients where paradoxical embolism may be the mechanism. 1, 4 The presence of PFO significantly increases risk of death, stroke, and peripheral arterial embolism in pulmonary embolism patients. 1, 3
Screening for Pulmonary Arteriovenous Malformations
The American College of Radiology recommends bubble studies as essential for diagnosing PAVMs, particularly in patients with hereditary hemorrhagic telangiectasia, with transthoracic echocardiography achieving 98-99% sensitivity. 1, 3, 4
Risk Stratification in Pulmonary Embolism
The American Heart Association recommends bubble studies for risk-stratifying patients with massive or submassive pulmonary embolism (Class IIb recommendation). 3, 4 Pulmonologists routinely screen for shunts when evaluating patients with elevated right ventricular systolic pressure (RVSP >45 mmHg). 1, 4
Quantification of Shunt Severity
A semi-quantitative grading system assesses shunt size based on the number of bubbles appearing in the left atrium: 1, 4
- Grade 0: No bubbles
- Grade 1: <30 bubbles
- Grade 2: Moderate left atrial filling
- Grade 3: Complete left atrial opacification
Shunts with >20 bubbles are considered large and clinically significant, correlating with higher risk of cerebral complications. 1, 4
Technical Approach: TTE vs TEE
Transthoracic echocardiography (TTE) with bubble study is the initial screening test recommended by the American College of Radiology due to its non-invasive nature, wide availability, and minimal risk. 1, 4
Transesophageal echocardiography (TEE) provides higher sensitivity (51% vs 32% for TTE) and should be considered when TTE is non-diagnostic, when higher sensitivity is needed, or when detailed anatomical assessment is required for procedural planning. 1, 3, 4 TEE offers superior visualization of the atrial septum and is as accurate as CT for assessing secundum atrial septal defect size. 1
Contrast Preparation Technique
Agitated saline is produced by mixing saline and 1 mL of air between two 10-mL syringes. 5 Research demonstrates that 18 agitations produce 1.86 times more bubbles than 6 agitations, and adding blood to the mixture produces 3.8 times more bubbles, potentially increasing test effectiveness. 5
Important Safety Considerations
Adverse events including air embolism occur in <1% of examinations. 1, 4 However, rare ischemic cerebrovascular complications can occur during or within 5 minutes of bubble studies, particularly in patients with cardiac or pulmonary shunts. 6 Five documented cases (all female, aged 42-90 years) included 3 ischemic strokes and 2 transient ischemic attacks, with small infarct volumes and mild deficits. 6
Distinction from Commercial Ultrasound Contrast Agents
This "bubble study" using agitated saline differs from commercial ultrasound contrast agents (like SonoVue, Luminity, Optison) that contain stabilized microbubbles with phospholipid or albumin shells encapsulating high-molecular-weight gas. 2, 3 Commercial agents are used for left ventricular opacification, myocardial perfusion assessment, and enhanced endocardial border delineation using specialized low mechanical index (MI <0.2) imaging modalities. 2